How to Help Your Patients Find Veozah in Stock: A Provider's Guide

Helping your patients find Veozah in stock

Your patient has moderate to severe hot flashes. You've prescribed Veozah (Fezolinetant). The clinical part was straightforward — but now your patient calls back saying they can't find it at their pharmacy.

This scenario is increasingly common. Veozah's combination of single-manufacturer supply, high retail cost, and prior authorization requirements creates a perfect storm of access challenges. Here's a practical guide to help your patients navigate them.

The current state of Veozah availability in 2026

Veozah is not on the FDA drug shortage list and has never been formally listed in shortage. Astellas Pharma, the sole manufacturer, reports no manufacturing or supply chain disruptions.

However, real-world availability remains inconsistent. The issue is not supply — it's distribution and stocking. Many pharmacies, particularly large chains, do not maintain Veozah in regular inventory. The drug must be specially ordered, which can take 1–3 business days and leaves patients without medication in the interim.

Why your patients can't find Veozah

Wholesaler allocation limits

Major wholesalers (McKesson, AmerisourceBergen, Cardinal Health) set ordering limits on specialty and high-cost brand medications. Even pharmacies with willing customers may be unable to order the quantity they need on a given day.

Demand concentration

Veozah serves a relatively specific patient population: women with moderate to severe VMS due to menopause who need or prefer a nonhormonal option. This niche demand means many pharmacies may only fill a few Veozah prescriptions per month — insufficient volume to justify keeping it in regular stock.

Pharmacy economics

With a retail price of $550–$765 per unit, stocking Veozah represents a meaningful inventory investment. Pharmacies operating on thin margins may opt to order on-demand rather than carry stock that could sit unsold.

Prior authorization lag

The time between when you write the prescription and when the patient's insurance approves it creates an unpredictable demand pattern for pharmacies. They can't stock what they can't forecast.

What you can do to help your patients

1. Use the Medfinder Provider Portal

The Medfinder Provider Portal allows you to search for pharmacies with Veozah in stock on behalf of your patients. Medfinder's dedicated team can contact pharmacies directly, verify availability, and help coordinate prescription transfers — saving your staff significant phone time.

Consider integrating a Medfinder search into your prescribing workflow for Veozah and other hard-to-find medications. It takes less time than fielding patient callback calls.

2. Advise patients to plan ahead

Coach your Veozah patients to contact their pharmacy at least one week before they need a refill. This gives the pharmacy time to order the medication from their wholesaler. For new prescriptions, discuss likely fill timelines upfront so patients set realistic expectations.

3. Recommend trying independent pharmacies

Independent pharmacies often have advantages when it comes to specialty medications:

• They may work with multiple wholesalers, giving them more sourcing flexibility
• Their inventory decisions are made locally, not by a corporate algorithm
• They're often more willing to special-order medications for individual patients
• Some have relationships with specialty distributors

If your practice doesn't already have relationships with independent pharmacies in your area, consider building them. They can be valuable partners for hard-to-find medications.

4. Prescribe with flexibility in mind

Veozah is only available in one dose (45 mg), so dose flexibility isn't directly applicable. However, having a backup plan ready is valuable:

• Discuss alternative options proactively with the patient at the initial visit
• Document the clinical rationale for Veozah in the chart to streamline prior authorization
• If the patient has previously tried and failed Brisdelle or HRT, note this clearly — it strengthens the authorization case and reduces delays

5. Ensure patients know about savings programs

Cost is a major barrier to Veozah adherence. At the time of prescribing, connect patients with:

• VEOZAH Savings Card: For commercially insured patients — pay as little as $0 first month, $30 refills, up to $4,000/year. Enroll at veozah.com/savings
• VEOZAH Support Solutions: For uninsured or underinsured patients — veozahsupportsolutions.com provides patient assistance and insurance navigation
• NeedyMeds and RxAssist: Additional resources for patients facing financial hardship

Having pre-printed savings card information available in exam rooms or at checkout can improve enrollment rates significantly.

Alternative options to discuss with patients

When Veozah is unavailable or unaffordable, consider these alternatives:

• Lynkuet (Elinzanetant): Dual NK1/NK3 receptor antagonist, FDA approved October 2025. Most pharmacologically similar to Veozah. May also address sleep disturbance. Does not carry the hepatotoxicity boxed warning. Consider as first alternative for patients who specifically need or prefer an NK receptor-targeting mechanism.
• Brisdelle (Paroxetine 7.5 mg): The only other FDA-approved nonhormonal VMS treatment. Lower cost, longer track record, no liver monitoring required. Contraindicated in patients taking tamoxifen. May cause SSRI-related side effects.
• Hormone Replacement Therapy: Remains the most effective treatment for VMS in eligible patients. Consider transdermal estrogen for lower thrombotic risk compared to oral formulations.
• Off-label options: Venlafaxine (37.5–75 mg/day), gabapentin (300–900 mg/day), and clonidine (0.1 mg twice daily) are commonly used with moderate evidence of benefit.

Streamlining your practice workflow

Managing Veozah access challenges shouldn't fall entirely on the prescriber. Here are workflow strategies that can help:

Designate a medication access point person

If your practice prescribes Veozah regularly, assign a staff member to handle insurance navigation, savings card enrollment, and pharmacy coordination. This reduces clinician interruptions and improves patient experience.

Build availability checks into prescribing

Before sending the prescription, run a quick Medfinder search or have staff call the patient's preferred pharmacy to confirm stock. This prevents the common scenario where a patient shows up to fill and gets turned away.

Keep a list of reliable pharmacies

Track which local pharmacies consistently stock or can quickly order Veozah. Share this list with patients and update it periodically. Independent pharmacies that serve your patient population are especially valuable to identify.

Pre-complete prior authorization documentation

Keep a template with common prior authorization elements for Veozah ready to go: diagnosis codes (N95.1 for menopausal VMS), documentation of step therapy failures if applicable, and baseline liver function results. This accelerates the approval process.

Final thoughts

Veozah access challenges are a systems problem — not a clinical one. As prescribers, you're uniquely positioned to help patients navigate these barriers by connecting them with the right tools and resources.

The Medfinder Provider Portal is purpose-built to help providers find medications for their patients. Combining it with proactive savings program enrollment and realistic patient education about timelines can dramatically improve your patients' experience with Veozah access.

For a patient-friendly version of this guide, share: How to find Veozah in stock near you (tools + tips).

Also see: Veozah shortage: What providers and prescribers need to know in 2026 and How to help patients save money on Veozah.